Sunday, August 3, 2025

Latest

Aurora Cannabis Replaces CFO, Conducts Reverse Split

Aurora Cannabis (TSX: ACB) is reporting this morning that it is replacing its chief financial officer in favor of an executive with decades of experience working for a leading multinational pharmaceutical company.

Glenn Ibbott, who has served in the role of CFO with Aurora since 2017, will be leaving the company’s leadership team effective February 21. Taking his place will be that of Simona King, a former executive from Bristol Myers-Squibb. King will be taking on the role following a 20 year career with the pharmaceutical giant, while Ibbott is expected to remain in an advisory role for several months to enable a smooth transition.

The change in leadership follows Aurora earlier this month reporting net revenue of $64.4 million for the fiscal third quarter of 2024, along with Adjusted EBITDA of $4.3 million.

Aurora meanwhile has also today completed a ten to one reverse split of its shares, which was conducted in an effort to meet minimum listing requirements for the Nasdaq. The company will have an estimated 47.6 million shares outstanding as a result.

Aurora Cannabis last traded at $0.52 on the TSX.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

San Dimas: First Majestic Silver’s Sleeper Asset

New Gold Q2 Earnings: Record Free Cash Flow

STLLR Gold: The Tower Gold PEA

Recommended

Tsunami Warnings Spread As Largest Quake Since 2011 Hits Russia

Northern Superior Intersects 1.75 g/t Gold Over 65.0 Metres At Philibert

Related News

Aurora Cannabis Revenues Decline 26% To $56.0 Million, Losses Increase

Aurora Cannabis (TSX: ACB) (NYSE: ACB) released its second quarter financials this morning, reporting net...

Thursday, February 13, 2020, 08:00:33 AM

Aurora Cannabis Sees Q4 Growth In Medical Cannabis While Consumer Segment Declines Materially

Aurora Cannabis (TSX: ACB) saw revenue of $67.4 million in its fiscal fourth quarter on...

Thursday, June 20, 2024, 08:27:10 AM

Aurora Cannabis Posts Loss of $158 Million for Third Quarter

Aurora Cannabis (TSX: ACB; NYSE: ACB) reported its third quarter 2019 earnings last night, posting...

Wednesday, May 15, 2019, 07:00:27 AM

Aurora Cannabis Rallies On 316% Earnings Jump In Q3 2025

Aurora Cannabis (NASDAQ: ACB) saw its shares surge after releasing fiscal Q3 2025 results, with...

Sunday, February 9, 2025, 11:28:00 AM

Saturated: The Canadian Cannabis Production Landscape

The Canadian cannabis landscape, in a word, is saturated. Despite the best intentions of sector...

Sunday, November 3, 2019, 09:00:16 AM